This section of the Siteman Cancer Center Web site includes information about research advances made by Washington University School of Medicine investigators at Siteman. Recent advances are highlighted first, followed by a link to an archive of research-oriented press releases.
Girls, Young Women Can Cut Risk of Early Breast Cancer Through Regular Exercise
May 13, 2008 -- Mothers, here's another reason to encourage your daughters to be physically active: Girls and young women who exercise regularly between the ages of 12 and 35 have a substantially lower risk of breast cancer before menopause compared to those who are less active, new research shows. |
 | | A tumor treated with fumagillin nanoparticles (left) is smaller than an untreated tumor. Nanoparticles containing an image enhancing metal (yellow) show that the treated tumor has much less blood vessel growth than the untreated tumor. |
Nano-sized Technology has Super-sized Effect on Tumors
April 2, 2008 -- Anyone facing chemotherapy would welcome an advance promising to dramatically reduce their dose of these often harsh drugs. Using nanotechnology, researchers at Washington University School of Medicine in St. Louis have taken a step closer to that goal.
|
 Fugitive Cancer Cells Can Be Blocked by Stopping Blood Cells That Aid Them
March 6, 2008 -- Cancer cells get a helping hand from platelets, specialized blood cells involved in clotting. Platelets shelter and feed tumor cells that stray into the bloodstream, making it easier for cancer to spread, or metastasize. Research at the Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis suggests that inactivating platelets could slow down or prevent metastasis. |
Mouse Model Tightly Matches Pediatric Tumor Syndrome, Will Speed Drug Hunt
March 1, 2008 -- Frustrated by the slow pace of new drug development for a condition that causes pediatric brain tumors, a neurologist at Washington University School of Medicine in St. Louis decided to try to fine-tune the animal models used to test new drugs. |
Insights into Cell Movement Likely to Aid Immune Study, Cancer Research
Jan. 8, 2008 -- Siteman Cancer Center scientists at Washington University School of Medicine in St. Louis have used yeast cells to better understand a collection of proteins associated with the formation of actin networks, which are essential to cell movement. |
Cancer Gene Drives Pivotal Decision in Early Brain Development
Nov. 12, 2007 -- A gene linked to pediatric brain tumors is an essential driver of early brain development, Siteman Cancer Center researchers at Washington University School of Medicine in St. Louis have found. |
Genome Researchers Uncover Novel Genetic Alterations in Lung Cancer
Nov. 4, 2007 -- Scientists at Washington University School of Medicine in St. Louis, working as part of an international team of researchers, have completed a massive effort to map the genetic changes underlying the most commonly diagnosed form of lung cancer. Their results are published in the Nov. 4 advance online issue of the journal Nature. |
 | | Mouse embryos stained to show MOF (green) and its histone tag (red) demonstrate that MOF is essential for cell proliferation. Embryos that don't have the gene for MOF (bottom row) are beginning to die by the time they reach the 32-cell stage of development. |
Discovery Could Increase Tumors' Sensitivity to Radiation Therapy
Nov. 1, 2007 -- To make tumors more sensitive to the killing power of radiation is a key aspiration for many radiation oncologists. Researchers at Washington University School of Medicine in St. Louis have uncovered new information that leads them closer to that goal.
|
Study Suggests Existing Drugs May Be Useful in Treating Brain Tumors
 Oct. 15, 2007 – Scientists have shown how developing brain tumors can turn an encounter with a signaling molecule from a fatal experience for the tumor cells into a cue for their own growth and multiplication. |
Bright Tumors, Dim Prospects
Sept. 12, 2007 -- It doesn't matter how small or large it is, if a cervical tumor glows brightly in a PET scan, it's apt to be more dangerous than dimmer tumors. That's the conclusion of a new study of cervical cancer patients at Washington University School of Medicine in St. Louis.
|
| |
| Press Release Archive |
| |